Abstract:Background: Emerging evidence suggests that neural crest-derived cells (NCCs) present important functions in peripheral nerve regeneration to correct the insufficiency of autogenous Schwann cells. Postmigratory NCCs have been successfully isolated from adult rat bone marrow in our previous work. In this study, we aim to provide neural crest-derived Schwann cell precursors (SCPs) for repair of nerve defects in adult rats, and partially reveal the mechanisms involved in neuroregeneration of cell therapy. Methods: A clonal cell line of neural crest precursors of rat bone marrow origin (rBM-NCPs) with SCP identity was expanded in adherent monolayer culture to ensure the stable cell viability of NCPs and potentiate the repair of nerve defects after rBM-NCPs implantation based on tissue engineering nerve grafts (TENG). Here the behavioral, morphological, and electrophysiological detection was performed to evaluate the therapy efficacy. We further investigated the treatment with NCP-conditioned medium (NCP-CM) to sensory neurons after exposure to oxygen-glucose-deprivation (OGD) and partially compared the expression of trophic factor genes in rBM-NCPs with that in mesenchymal stem cells of bone marrow origin (rBM-MSCs). Results: It was showed that the constructed TENG with rBM-NCPs loaded into silk fibroin fiber scaffolds/chitosan conduits repaired 10-mm long sciatic nerve defects more efficiently than conduits alone. The axonal regrowth, remyelination promoted the reinnervation of the denervated hind limb muscle and skin and thereby alleviated muscle atrophy and facilitated the rehabilitation of motor and sensory function. Moreover, it was demonstrated that treatment with NCP-CM could restore the cultured primary sensory neurons after OGD through trophic factors including epidermal growth factor (EGF), platelet-derived growth factor alpha (PDGFα), ciliary neurotrophic factor (CNTF), and vascular endothelial growth factor alpha (VEGFα). Conclusions: In summary, our findings indicated that monolayer-cultured rBM-NCPs cell-based therapy might effectively repair peripheral nerve defects partially through secreted trophic factors, which represented the secretome of rBM-NCPs differing from that of rBM-MSCs.

Neural stem cells as potential target cells for the treatment of neuropathic pain

Application of cell transplantation in the treatment of neuropathic pain

Stem Cells in the Treatment of Neuropathic Pain: Research Progress of Mechanism

Therapeutic role of neural stem cells in neurological diseases

Olfactory ensheathing cells and neuropathic pain

The Application of Neural Stem/Progenitor Cells for Regenerative Therapy of Spinal Cord Injury

Neural Stem Cells Enhance Nerve Regeneration after Sciatic Nerve Injury in Rats

Cell therapy for neuropathic pain

Piezotronic effect for in situ electrostimulation of neural stem cell therapy for nerve injury

Application of stem cells in peripheral nerve regeneration

Potential role of Schwann cells in neuropathic pain

Transplantation of NSCs with OECs Alleviates Neuropathic Pain Associated with NGF Downregulation in Rats Following Spinal Cord Injury

Advances of Schwann cells in peripheral nerve regeneration: From mechanism to cell therapy

Neuronally Differentiated Adipose-Derived Stem Cells and Aligned PHBV Nanofiber Nerve Scaffolds Promote Sciatic Nerve Regeneration

Stem Cell and Peripheral Nerve Regeneration

Bone marrow-derived neural crest precursors improve nerve defect repair partially through secreted trophic factors

Engineered Schwann Cell-Based Therapies for Injury Peripheral Nerve Reconstruction

Therapeutic Effects of Peripherally Administrated Neural Crest Stem Cells on Pain and Spinal Cord Changes after Sciatic Nerve Transection

The Effect of Schwann Cells/Schwann Cell-Like Cells on Cell Therapy for Peripheral Neuropathy

Cell transplantation as a pain therapy targets both analgesia and neural repair.

Augmenting Peripheral Nerve Regeneration with Adipose-Derived Stem Cells